Use of Automated Medication Adherence Monitoring in Bipolar Disorder Research: Pitfalls, Pragmatics, and Possibilities

Overview

Journal Ther Adv Psychopharmacol

Specialty Psychiatry

Date 2015 Aug 5

PMID 26240747

Citations 20

Authors

Jennifer B Levin

Johnny Sams

Curtis Tatsuoka

Kristin A Cassidy

Martha Sajatovic

Affiliations

Soon will be listed here.

Abstract

Objectives: Medication nonadherence occurs in 20-60% of persons with bipolar disorder (BD) and is associated with serious negative outcomes, including relapse, hospitalization, incarceration, suicide and high healthcare costs. Various strategies have been developed to measure adherence in BD. This descriptive paper summarizes challenges and workable strategies using electronic medication monitoring in a randomized clinical trial (RCT) in patients with BD.

Methods: Descriptive data from 57 nonadherent individuals with BD enrolled in a prospective RCT evaluating a novel customized adherence intervention versus control were analyzed. Analyses focused on whole group data and did not assess intervention effects. Adherence was assessed with the self-reported Tablets Routine Questionnaire and the Medication Event Monitoring System (MEMS).

Results: The majority of participants were women (74%), African American (69%), with type I BD (77%). Practical limitations of MEMS included misuse in conjunction with pill minders, polypharmacy, cost, failure to bring to research visits, losing the device, and the device impacting baseline measurement. The advantages were more precise measurement, less biased recall, and collecting data from past time periods for missed interim visits.

Conclusions: Automated devices such as MEMS can assist investigators in evaluating adherence in patients with BD. Knowing the anticipated pitfalls allows study teams to implement preemptive procedures for successful implementation in BD adherence studies and can help pave the way for future refinements as automated adherence assessment technologies become more sophisticated and readily available.

Citing Articles

A 6-month, prospective, randomized controlled trial of customized adherence enhancement versus a bipolar-specific educational control in poorly adherent adolescents and young adults living with bipolar disorder.

Levin J, DelBello M, Modi A, Briggs F, Forthun L, McVoy M Bipolar Disord. 2024; 26(7):696-707.

PMID: 39231780 PMC: 11560489. DOI: 10.1111/bdi.13489.

What Do We Know about Medication Adherence Interventions in Inflammatory Bowel Disease, Multiple Sclerosis and Rheumatoid Arthritis? A Scoping Review of Randomised Controlled Trials.

King K, McGuinness S, Watson N, Norton C, Chalder T, Czuber-Dochan W Patient Prefer Adherence. 2023; 17:3265-3303.

PMID: 38111690 PMC: 10725835. DOI: 10.2147/PPA.S424024.

Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios.

Luca F, Oliva F, Abrignani M, Di Fusco S, Parrini I, Canale M J Clin Med. 2023; 12(18).

PMID: 37762897 PMC: 10531873. DOI: 10.3390/jcm12185955.

Adherence to Oral Chemotherapy in Acute Lymphoblastic Leukemia during Maintenance Therapy in Children, Adolescents, and Young Adults: A Systematic Review.

Zeng X, Heneghan M, Badawy S Curr Oncol. 2023; 30(1):720-748.

PMID: 36661705 PMC: 9858168. DOI: 10.3390/curroncol30010056.

A randomized controlled trial of customized adherence enhancement (CAE-E): study protocol for a hybrid effectiveness-implementation project.

Levin J, Briggs F, Blixen C, Bauer M, Einstadter D, Albert J Trials. 2022; 23(1):634.

PMID: 35927740 PMC: 9351150. DOI: 10.1186/s13063-022-06517-0.

References

Sajatovic M, Ignacio R, West J, Cassidy K, Safavi R, Kilbourne A . Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic. Compr Psychiatry. 2009; 50(2):100-7. PMC: 2746444. DOI: 10.1016/j.comppsych.2008.06.008. View

Sajatovic M, Velligan D, Weiden P, Valenstein M, Ogedegbe G . Measurement of psychiatric treatment adherence. J Psychosom Res. 2010; 69(6):591-9. PMC: 3930068. DOI: 10.1016/j.jpsychores.2009.05.007. View

Diaz E, LEVINE H, Sullivan M, Sernyak M, Hawkins K, Cramer J . Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia. J Psychiatry Neurosci. 2001; 26(4):325-9. PMC: 167186. View

Haberer J, Kahane J, Kigozi I, Emenyonu N, Hunt P, Martin J . Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav. 2010; 14(6):1340-6. PMC: 2974938. DOI: 10.1007/s10461-010-9799-4. View

Zeller A, Schroeder K, Peters T . Electronic pillboxes (MEMS) to assess the relationship between medication adherence and blood pressure control in primary care. Scand J Prim Health Care. 2007; 25(4):202-7. PMC: 3379760. DOI: 10.1080/02813430701651954. View

Post R, Altshuler L, Frye M, Suppes T, Keck Jr P, McElroy S . Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder. J Clin Psychiatry. 2010; 71(9):1176-86. DOI: 10.4088/JCP.08m04811yel. View

Byerly M, Fisher R, Whatley K, Holland R, Varghese F, Carmody T . A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Res. 2005; 133(2-3):129-33. DOI: 10.1016/j.psychres.2004.11.002. View

Osterberg L, Blaschke T . Adherence to medication. N Engl J Med. 2005; 353(5):487-97. DOI: 10.1056/NEJMra050100. View

Peet M, Harvey N . Lithium maintenance: 1. A standard education programme for patients. Br J Psychiatry. 1991; 158:197-200. DOI: 10.1192/bjp.158.2.197. View

10.

Sajatovic M, Levin J, Fuentes-Casiano E, Cassidy K, Tatsuoka C, Jenkins J . Illness experience and reasons for nonadherence among individuals with bipolar disorder who are poorly adherent with medication. Compr Psychiatry. 2011; 52(3):280-7. PMC: 3140848. DOI: 10.1016/j.comppsych.2010.07.002. View

11.

OCarroll R, Chambers J, Dennis M, Sudlow C, Johnston M . Improving adherence to medication in stroke survivors: a pilot randomised controlled trial. Ann Behav Med. 2013; 46(3):358-68. DOI: 10.1007/s12160-013-9515-5. View

12.

Medic G, Higashi K, Littlewood K, Diez T, Granstrom O, Kahn R . Dosing frequency and adherence in chronic psychiatric disease: systematic review and meta-analysis. Neuropsychiatr Dis Treat. 2013; 9:119-31. PMC: 3552550. DOI: 10.2147/NDT.S39303. View

13.

Pearson C, Simoni J, Hoff P, Kurth A, Martin D . Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues. AIDS Behav. 2006; 11(2):161-73. PMC: 5096443. DOI: 10.1007/s10461-006-9133-3. View

14.

Colom F, Vieta E, Tacchi M, Sanchez-Moreno J, Scott J . Identifying and improving non-adherence in bipolar disorders. Bipolar Disord. 2005; 7 Suppl 5:24-31. DOI: 10.1111/j.1399-5618.2005.00248.x. View

15.

Svarstad B, Shireman T, Sweeney J . Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatr Serv. 2001; 52(6):805-11. DOI: 10.1176/appi.ps.52.6.805. View

16.

Harvey N . The development and descriptive use of the Lithium Attitudes Questionnaire. J Affect Disord. 1991; 22(4):211-9. DOI: 10.1016/0165-0327(91)90067-3. View

17.

Velligan D, Lam Y, Glahn D, Barrett J, Maples N, Ereshefsky L . Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull. 2006; 32(4):724-42. PMC: 2632258. DOI: 10.1093/schbul/sbj075. View

18.

Arnet I, Walter P, Hersberger K . Polymedication Electronic Monitoring System (POEMS) - a new technology for measuring adherence. Front Pharmacol. 2013; 4:26. PMC: 3595531. DOI: 10.3389/fphar.2013.00026. View

19.

Liu H, Golin C, Miller L, Hays R, Beck C, Sanandaji S . A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001; 134(10):968-77. DOI: 10.7326/0003-4819-134-10-200105150-00011. View

20.

Bova C, Fennie K, Knafl G, Dieckhaus K, Watrous E, Williams A . Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations. AIDS Behav. 2005; 9(1):103-10. DOI: 10.1007/s10461-005-1685-0. View